Back to search
FDAFDA · Food and drugs·Recall number D-0371-2024

Rocuronium Bromide Injection, Preservative Free, 10 mg / mL, Multiple-Dose Vial 10 mL, Rx only, Mfg: Auromedics Pharma LLC, NDC 55150-226-10

Published March 20, 2024 · Recall initiated: February 7, 2024

Summary

FDA records drug Class II recall D-0371-2024, published March 20, 2024 and initiated February 7, 2024. Recalling firm: Mckesson Medical-Surgical Inc. Corporate Office; Status: Terminated; Reported quantity: 70 vials; Lot: 1064081. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

cGMP Deviations: Products were stored outside the drug label specifications.

What to do

Voluntary: Firm initiated · Letter

Get an email if ROCURONIUM BROMIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ROCURONIUM BROMIDE
Manufacturer
Mckesson Medical-Surgical Inc. Corporate Office
Distributor
Product was distributed to three direct accounts in NM, AZ and UT.
UPC
0355150226108
Lot
1064081
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Rocuronium Bromide Injection, Preservative Free, 10 mg / mL, Multiple-Dose Vial 10 mL, Rx only, Mfg: Auromedics Pharma LLC, NDC 55150-226-10 recalled?

Yes. FDA published recall D-0371-2024 on March 20, 2024. Reported hazard: cGMP Deviations: Products were stored outside the drug label specifications.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ROCURONIUM BROMIDE. UPC: 0355150226108.